Literature DB >> 6846121

Adverse effects of febrile state on cardiac performance.

M T Haupt, E C Rackow.   

Abstract

The hemodynamic characteristics of 36 febrile patients were studied when temperature was greater than 100 degrees F and after resolution of fever (temperature less than or equal to 100 degrees F). The patients were divided into those with bacterial infection (group I, n = 26) and those whose fever was noninfectious in etiology (group II, n = 10). Analysis of patients likely to have coronary artery disease (CAD) (subset A, n = 12) and those unlikely to have CAD (subset B, n = 7) was carried out. To maintain constant preload, pulmonary artery wedge pressure varied by not more than 2 mm Hg in all patients. Resolution of fever was associated with a 23% increase in stroke volume index (SVI) and 37% increase in left ventricular stroke work index (LVSWI) for group I (p less than 0.01). Group II showed a 27% increase in SVI and a 38% increase in LVSWI (p less than 0.05). Both subsets A and B showed significant increases in LVSWI after resolution of fever. We found evidence of decreased left ventricular performance during the febrile state in patients with and without infections. Since all groups and subsets maintained a normal or high cardiac index associated with increased heart rate during the febrile state, the tachycardic response of the febrile patient may serve to maintain cardiac output when myocardial performance is impaired.

Entities:  

Mesh:

Year:  1983        PMID: 6846121     DOI: 10.1016/0002-8703(83)90238-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

1.  Clinical and demographic factors associated with antipyretic use in gram-negative severe sepsis and septic shock.

Authors:  Nicholas M Mohr; Brian M Fuller; Lee P Skrupky; Hawnwan Moy; Robert Alunday; Scott T Micek; Richard E Fagley
Journal:  Ann Pharmacother       Date:  2011-09-20       Impact factor: 3.154

2.  Counterpoint: Should antipyretic therapy be given routinely to febrile patients in septic shock? No.

Authors:  Anne M Drewry; Richard S Hotchkiss
Journal:  Chest       Date:  2013-10       Impact factor: 9.410

Review 3.  Temperature Management in the ICU.

Authors:  Anne Drewry; Nicholas M Mohr
Journal:  Crit Care Med       Date:  2022-04-15       Impact factor: 9.296

4.  Randomized trial of the effect of antipyresis by metamizol, propacetamol or external cooling on metabolism, hemodynamics and inflammatory response.

Authors:  Valerio Gozzoli; Miriam M Treggiari; Gian-Reto Kleger; Pascale Roux-Lombard; Marc Fathi; Claude Pichard; Jacques-André Romand
Journal:  Intensive Care Med       Date:  2004-01-13       Impact factor: 17.440

Review 5.  [Therapy of hyperthermia in sepsis and septic shock. Necessary or injurious?].

Authors:  H Theilen; M Ragaller
Journal:  Anaesthesist       Date:  2007-09       Impact factor: 1.041

6.  Febrile illness in the athlete.

Authors:  Natalie A Dick; Jason J Diehl
Journal:  Sports Health       Date:  2014-05       Impact factor: 3.843

7.  Uncoupling of oxidative phosphorylation and ATP synthase reversal within the hyperthermic heart.

Authors:  Amelia Power; Nicholas Pearson; Toan Pham; Carlos Cheung; Anthony Phillips; Anthony Hickey
Journal:  Physiol Rep       Date:  2014-09-28

Review 8.  Antipyretic Therapy in Critically Ill Septic Patients: A Systematic Review and Meta-Analysis.

Authors:  Anne M Drewry; Enyo A Ablordeppey; Ellen T Murray; Carolyn R T Stoll; Sonya R Izadi; Catherine M Dalton; Angela C Hardi; Susan A Fowler; Brian M Fuller; Graham A Colditz
Journal:  Crit Care Med       Date:  2017-05       Impact factor: 7.598

9.  Optimizing Our Patients' Entropy Production as Therapy? Hypotheses Originating from the Physics of Physiology.

Authors:  Andrew J E Seely
Journal:  Entropy (Basel)       Date:  2020-09-29       Impact factor: 2.524

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.